114 related articles for article (PubMed ID: 26551968)
1. Monitoring testosterone levels in testosterone-treated men.
Winters SJ
Curr Med Res Opin; 2016; 32(2):271-2. PubMed ID: 26551968
[TBL] [Abstract][Full Text] [Related]
2. Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone.
Wasserman P; Segal-Maurer S; Rubin D
J Sex Med; 2008 Jan; 5(1):241-7. PubMed ID: 17961146
[TBL] [Abstract][Full Text] [Related]
3. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
[TBL] [Abstract][Full Text] [Related]
4. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism.
Loves S; Ruinemans-Koerts J; de Boer H
Eur J Endocrinol; 2008 May; 158(5):741-7. PubMed ID: 18426834
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes.
Kapoor D; Channer KS; Jones TH
Diab Vasc Dis Res; 2008 Jun; 5(2):135-7. PubMed ID: 18537102
[TBL] [Abstract][Full Text] [Related]
6. Associations of vitamin D status and vitamin D-related polymorphisms with sex hormones in older men.
Rafiq R; van Schoor NM; Sohl E; Zillikens MC; Oosterwerff MM; Schaap L; Lips P; de Jongh RT
J Steroid Biochem Mol Biol; 2016 Nov; 164():11-17. PubMed ID: 26610790
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone-binding globulin changes with androgen replacement.
Plymate SR; Leonard JM; Paulsen CA; Fariss BL; Karpas AE
J Clin Endocrinol Metab; 1983 Sep; 57(3):645-8. PubMed ID: 6683724
[TBL] [Abstract][Full Text] [Related]
8. Hypogonadism and diabetes.
Betancourt-Albrecht M; Cunningham GR
Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
[TBL] [Abstract][Full Text] [Related]
10. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
Winters SJ; Wang C;
J Androl; 2010; 31(3):281-7. PubMed ID: 19959827
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone supplementation on symptoms in men with hypogonadism.
Ramasamy R; Wilken N; Scovell JM; Lipshultz LI
Eur Urol; 2015 Jan; 67(1):176-177. PubMed ID: 25199721
[TBL] [Abstract][Full Text] [Related]
12. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study.
Chubb SA; Hyde Z; Almeida OP; Flicker L; Norman PE; Jamrozik K; Hankey GJ; Yeap BB
Eur J Endocrinol; 2008 Jun; 158(6):785-92. PubMed ID: 18505902
[TBL] [Abstract][Full Text] [Related]
13. The role of sex hormone-binding globulin (SHBG), testosterone, and other sex steroids, on the development of type 2 diabetes in a cohort of community-dwelling middle-aged to elderly men.
Gyawali P; Martin SA; Heilbronn LK; Vincent AD; Taylor AW; Adams RJT; O'Loughlin PD; Wittert GA
Acta Diabetol; 2018 Aug; 55(8):861-872. PubMed ID: 29845345
[TBL] [Abstract][Full Text] [Related]
14. Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism.
Tengstrand B; Carlström K; Hafström I
Rheumatology (Oxford); 2002 Mar; 41(3):285-9. PubMed ID: 11934965
[TBL] [Abstract][Full Text] [Related]
15. Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men.
Nielsen TL; Hagen C; Wraae K; Brixen K; Petersen PH; Haug E; Larsen R; Andersen M
J Clin Endocrinol Metab; 2007 Jul; 92(7):2696-705. PubMed ID: 17426100
[TBL] [Abstract][Full Text] [Related]
16. Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.
Zumoff B; Strain GW; Miller LK; Rosner W; Levit CD; Miller EH; Rosenfeld RS
Int J Obes; 1988; 12(6):525-31. PubMed ID: 3148562
[TBL] [Abstract][Full Text] [Related]
17. Decreased androgen levels and obesity in men.
Vermeulen A
Ann Med; 1996 Feb; 28(1):13-5. PubMed ID: 8932500
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight.
Calderón B; Gómez-Martín JM; Vega-Piñero B; Martín-Hidalgo A; Galindo J; Luque-Ramírez M; Escobar-Morreale HF; Botella-Carretero JI
Andrology; 2016 Jan; 4(1):62-7. PubMed ID: 26663756
[TBL] [Abstract][Full Text] [Related]
19. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD
J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P
Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
